Cancer Research Audrey Hepburn  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 799-806, March 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darzynkiewicz, Z.
Right arrow Articles by Melamed, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darzynkiewicz, Z.
Right arrow Articles by Melamed, M. R.

Interactions of Rhodamine 123 with Living Cells Studied by Flow Cytometry1

Z. Darzynkiewicz, F. Traganos, L. Staiano-Coico, J. Kapuscinski and M. R. Melamed

Memorial Sloan-Kettering Cancer Center, New York, New York 10021

The cationic fluorochrome rhodamine 123 (R123), reported to bind specifically to mitochondria of living cells, was presently investigated with respect to its uptake by a variety of cell types in various functional states and the subsequent effect of the dye on cell growth. The emission spectrum of R123 taken up by cells undergoes a 12-nm red shift, suggesting formation of a complex. Cells accumulate R123 rapidly; near maximum binding is reached after 5 to 10 min, regardless of the temperature (0–37°) of incubation. There is a dose-dependent relationship between R123 concentration in the medium and the dye accumulation in the cell that covers the range of 0.1 to 10.0 and 0.1 to 5.0 µg of R123 per ml under equilibrium and nonequilibrium conditions, respectively. Some leakage of the dye from cells occurs, following their transfer into dye-free medium. Despite the leakage, the intracellular dye can be detected after at least two cell divisions, thus indicating that: (a) the R123-labeled cells divide; (b) during division, labeled mitochondria are distributed into the daughter cells; and (c) R123 may be used as a cell tracer.

Cell death often is accompanied by a transient increase in R123 fluorescence. Dead cells exhibit either uniform, strong fluorescence or show a patchy labeling pattern suggesting swollen mitochondria. With time (4 to 8 hr), dead cells lose ability to retain R123 and lyse. Uptake of R123 by living cells is increased during the transition from quiescence into the cycle, and a decrease is seen when Friend leukemia cells undergo erythroid differentiation; in all cases, changes in R123 uptake are correlated with changes in cellular RNA content. Simultaneous cell staining with R123 and ethidium or propidium provides a rapid assay of the viability of the cells and their metabolic state, i.e., as related to proliferation or motility.

Pulse-labeling of cells with up to 10 µg of R123 per ml has no significant effect on their immediate growth and cloning efficiency. In the continuous presence of R123, however, cells become specifically arrested in the G1A compartment, i.e., in early G1 phase. Detailed analysis of the cell cycle kinetics reveals that cell progression through all phases is slowed 4 hr after addition of R123. Cell exit from G1A, however, is affected as early as 2 hr following addition of R123, and with time the cells are unable to leave this compartment at all. Uncharged rhodamine dyes (rhodamine 110 and rhodamine B) do not accumulate in mitochondria and are without effect on the cell cycle. The cytostatic effect of R123 is discussed in light of the dye specificity for mitochondrial membranes and the disruption of cell energy metabolism, resulting in the inability of the cells to attain a critical content of essential components (i.e., ribosomal RNA), necessary for cell entrance into the prereplicative (G1B) compartment of G1 phase.

1 Supported by Grants CA 28704 and CA 23296 from the National Cancer Institute.

Received 8/18/81. Accepted 11/13/81.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
N. Lopez-Sanchez, J.-R. Rodriguez, and J. M. Frade
Mitochondrial c-Jun NH2-Terminal Kinase Prevents the Accumulation of Reactive Oxygen Species and Reduces Necrotic Damage in Neural Tumor Cells that Lack Trophic Support
Mol. Cancer Res., January 1, 2007; 5(1): 47 - 60.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Kuhl, A. Atzberger, F. Iborra, B. Nieswandt, C. Porcher, and P. Vyas
GATA1-Mediated Megakaryocyte Differentiation and Growth Control Can Be Uncoupled and Mapped to Different Domains in GATA1
Mol. Cell. Biol., October 1, 2005; 25(19): 8592 - 8606.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
Z. Humlova, M. Vokurka, M. Esteban, and Z. Melkova
Vaccinia virus induces apoptosis of infected macrophages
J. Gen. Virol., November 1, 2002; 83(11): 2821 - 2832.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. B. Walter, M. D. Knutson, A. Paler-Martinez, S. Lee, Y. Xu, F. E. Viteri, and B. N. Ames
Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats
PNAS, February 19, 2002; 99(4): 2264 - 2269.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
D. J. Castro, R. E. Saxton, H. R. Fetterman, D. J. Castro, and P. H. Ward
Rhodamine 123 as a Chemosensitizing Agent for Argon Laser Therapy: A New Technique for Treatment of Superficial Malignancies
Arch Otolaryngol Head Neck Surg, November 1, 1987; 113(11): 1176 - 1182.
[Abstract] [PDF]


Home page
ScienceHome page
S. Bernal, T. Lampidis, I. Summerhayes, and L. Chen
Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro
Science, December 10, 1982; 218(4577): 1117 - 1119.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.